Position of SGLT2i in prediabetes: A systematic review of literature

Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, et al. (2002). Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616-1622. Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, et al.; EMBRACE (2018). Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat 39:593-620. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, etal.; ACMG Laboratory Quality Assurance Committee (2015). Standards and guidelines for the interpretation of sequence variants: ajoint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405-424. Sehouli J, Alfaro V, Gonz & aacute;lez-Martin A (2012). Trabectedin plus pegylated liposomal doxorubicin in the treatment of patients with partially platinum- sensitive ovarian cancer: current evidence and future perspectives. Ann Oncol 23:556-562. Shao D, Cheng S, Guo F, Zhu C, Yuan Y, Hu K, et al. (2020). Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals. Cancer Sci 111:647-657. X, L, Kong B, J, R, H, (2017). multicenter prevalence study of germline BRCA1 and BRCA2 mutations in Chinese ovarian cancer patients. IntJ Gynecol Cancer 27:1650-1657. Wu Z, Zhang Q, Jin Y, Zhang X, Chen Y, Yang C, et al. (2024). Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area. BMC Cancer 24:411. Yousif HM, Mohammed RA, Missawi HM, Elsawaf ZM, Albasri AM (2019). Histopathological patterns of primary malignant ovarian neoplasms in different age groups in Almadinah Almunawwarah region, KSA. J Taibah Univ Med Sci 14:73-78. Zadabedini Masouleh T, Etchegary H, Hodgkinson K, Wilson BJ, Dawson L (2023). Beyond sterilization: a comprehensive review on the safety and efficacy of opportunistic salpingectomy as a preventative strategy for ovarian cancer. Curr Oncol 30:10152-10165. Zhang S, Royer R, Li S, McLaughlin JR, Rosen B, Risch HA, et al. (2011). Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol 121:353-357.